Creatine Activity as a Neuromodulator in the Central Nervous System - PMC
Paxil (paroxetine), a selective serotonin reuptake inhibitor (SSRI), and creatine have different pharmacological profiles, but recent research highlights potential synergies and clinical considerations when they are used together. Therapeutic Augmentation and Synergy Paxil And Creatine
Recent clinical studies suggest that adding creatine to SSRI therapy may enhance and accelerate treatment response for depression. Creatine Activity as a Neuromodulator in the Central
While generally considered safe, certain physiological interactions warrant professional medical oversight. : In a double-blind trial involving women with
: In a double-blind trial involving women with major depressive disorder, creatine augmentation (5 g/day) of an SSRI led to significantly greater improvements in Hamilton Depression Rating Scale (HAM-D) scores as early as week 2 compared to placebo.
: Evidence from animal models indicates that creatine may interact with the serotonergic system, potentially enhancing the efficacy of medications like Paxil. Clinical Monitoring and Safety